← Back to guidelines
Cardiology21 papers

Phakomatosis cesiomarmorata

Last edited: 4/14/2026

Overview

Phakomatosis cesiomarmorata, often part of the broader phakomatosis pigmentovascularis spectrum, involves coexisting cutaneous vascular and pigmentary anomalies. It can present with additional systemic manifestations beyond skin and ocular involvement, affecting multiple organ systems including venous structures and potentially reproductive organs 134.

Diagnosis

  • Clinical Features: Presence of extensive cutaneous vascular (capillary) and pigmentary anomalies.
  • Specific Associations: Consider rare associations such as extensive venous anomalies (abdominal varicosities), persistent superior vena cava anomalies, natal teeth, and renal angiomas 13.
  • Ocular Evaluation: Essential due to potential neuro-ophthalmologic manifestations 2.
  • Imaging and Histology: Utilize imaging (e.g., MRI, ultrasound) and histological examination for detailed assessment of vascular and pigmented lesions 34.
  • Management

  • Supportive Care: Focus on managing complications such as bleeding (e.g., in gynecological presentations) and symptomatic venous anomalies 4.
  • Multidisciplinary Approach: Involvement of dermatologists, ophthalmologists, neurologists, and potentially gynecologists based on organ involvement 24.
  • Specific Interventions: Tailored to individual manifestations (e.g., laser therapy for vascular lesions, surgical intervention for severe venous anomalies) 3.
  • Special Populations

  • Pediatrics: Early recognition crucial due to potential systemic associations like those seen in infants 1.
  • Gynecological Involvement: Recognize reproductive system involvement as a possible presentation mode, requiring gynecological evaluation 4.
  • Key Recommendations

  • Conduct thorough neuro-ophthalmologic evaluations in patients with suspected phakomatosis to identify CNS and ocular manifestations (Evidence: Moderate 2).
  • Consider comprehensive imaging and histological assessments to diagnose associated systemic anomalies such as renal angiomas and venous malformations (Evidence: Weak 3).
  • Employ a multidisciplinary team approach tailored to the specific organ system involvement observed in individual cases (Evidence: Expert opinion 4).
  • References

    1 Singal A, Mittal H, Aggarwal A, Das S, Manchanda S. Phacomatosis pigmentovascularis type 2b (phacomatosis cesioflammea) with double superior vena cava, abdominal varicosities, and natal tooth: Novel associations. Pediatric dermatology 2018. link 2 Kerrison JB. Neuro-ophthalmology of the phacomatoses. Current opinion in ophthalmology 2000. link 3 Di Landro A, Tadini GL, Marchesi L, Cainelli T. Phakomatosis pigmentovascularis: A new case with renal angiomas and some considerations about the classification. Pediatric dermatology 1999. link 4 Milano CT, Gleicher N. A gynecologic presentation of mixed phakomatosis. Diagnostic gynecology and obstetrics 1980. link

    Original source

    1. [1]
    2. [2]
      Neuro-ophthalmology of the phacomatoses.Kerrison JB Current opinion in ophthalmology (2000)
    3. [3]
      Phakomatosis pigmentovascularis: A new case with renal angiomas and some considerations about the classification.Di Landro A, Tadini GL, Marchesi L, Cainelli T Pediatric dermatology (1999)
    4. [4]
      A gynecologic presentation of mixed phakomatosis.Milano CT, Gleicher N Diagnostic gynecology and obstetrics (1980)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG